Events
Centauri Therapeutics, an immunotherapy company active in oncology and infectious diseases, announces that it will attend the following scientific and investor conferences
Responses observed in patients with microsatellite stable (MSS) colorectal cancer, a disease not historically sensitive to checkpoint inhibition
Hutchison China MediTech Limited presented the results of the Phase III study of surufatinib in advanced neuroendocrine tumors – extra-pancreatic at the 2019 European Society for Medical Oncology Congress.
Phase 1/2, open-label, multicenter study ongoing to evaluate KY1044 as a single agent and in combination with anti-PD-L1 (atezolizumab) in adult patients with advanced malignancies Cambr
Retrophin, Inc. announced that Eric Dube, Ph.D., chief executive officer, will present at the 2019 Cantor Global Healthcare Conference in New York City on Thursday, October 3, 2019 at 5:20 p.m. ET.
MyoKardia, Inc., announced that Taylor Harris, Chief Financial Officer, will participate in a fireside chat at the 2019 Cantor Global Healthcare Conference on Thursday, October 3, 2019, at 4:10 p.m. ET in New York, NY.
SphingoTec GmbH announced that novel data on its sphingotest penKid assay for Proenkephalin, a unique and proprietary biomarker for real-time assessment of kidney function, will be presented at the 32nd Annual Congress of the European Society of Intensive Care Medicine taking place in Berlin on September 28 to October 2, 2019.
SCORR Marketing is excited to announce that Krystle Buntemeyer, president of SCORR Marketing, is the recipient of the 2019 Distinguished Young Alumni Award from the University of Nebraska at Kearney Alumni Association.
Assertio Therapeutics, Inc. announced that members of senior management will participate at the Annual Cantor Fitzgerald Global Healthcare Conference in a session scheduled for 12:35 p.m. ET, Friday, October 4, 2019 in New York, NY.
Helsinn announces an abstract has been accepted for oral presentation at the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Meeting 2019 taking place from September 26-28, 2019 in Athens, Greece.
PRESS RELEASES